Geneos Wealth Management’s Capital Group Core Bond ETF CGCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$154K Sell
5,850
-1,020
-15% -$27.1K ﹤0.01% 1042
2025
Q4
$182K Buy
6,870
+1,799
+35% +$47.9K ﹤0.01% 954
2025
Q3
$135K Sell
5,071
-371,624
-99% -$9.8M ﹤0.01% 1026
2025
Q2
$9.91M Buy
376,695
+102,650
+37% +$2.68M 0.24% 99
2025
Q1
$7.2M Buy
+274,045
New +$7.13M 0.1% 242

Other funds holding CGCB

Geneos Wealth Management's CGCB Position: Q1 2026 in Review

Geneos Wealth Management reduced its Capital Group Core Bond ETF (CGCB) stake by 15% in Q1 2026, selling an estimated $27.1K and leaving 5,850 shares worth $154K. The position accounts for ﹤0.01% of the portfolio, ranked #1042.

Geneos Wealth Management first reported a position in CGCB in Q1 2025 and has held it in 5 quarters since. The position peaked at $9.91M in Q2 2025. 252 funds tracked by Wall St. Rank hold CGCB as of Q1 2026.

  • Geneos Wealth Management held 5,850 shares of Capital Group Core Bond ETF worth $154K as of Q1 2026.
  • Geneos Wealth Management sold 1,020 Capital Group Core Bond ETF shares in Q1 2026, an estimated $27.1K.
  • Capital Group Core Bond ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1042 holding.
  • Geneos Wealth Management first reported a position in Capital Group Core Bond ETF in Q1 2025 and has held it in 5 quarters since.
  • Geneos Wealth Management's Capital Group Core Bond ETF position peaked at $9.91M in Q2 2025.
  • 252 funds tracked by Wall St. Rank held Capital Group Core Bond ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.